Colgate-Palmolive (NYSE:CL) Position Boosted by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise grew its position in Colgate-Palmolive (NYSE:CL) by 40.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,579 shares of the company’s stock after buying an additional 10,223 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Colgate-Palmolive were worth $3,452,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in CL. GUNN & Co INVESTMENT MANAGEMENT INC. acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $1,636,000. Choreo LLC lifted its position in shares of Colgate-Palmolive by 40.3% in the fourth quarter. Choreo LLC now owns 7,024 shares of the company’s stock worth $560,000 after purchasing an additional 2,018 shares in the last quarter. Mission Wealth Management LP purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $254,000. Wilbanks Smith & Thomas Asset Management LLC lifted its position in shares of Colgate-Palmolive by 2.0% in the fourth quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 15,298 shares of the company’s stock worth $1,219,000 after purchasing an additional 302 shares in the last quarter. Finally, Fisher Asset Management LLC lifted its position in shares of Colgate-Palmolive by 1,019.7% in the fourth quarter. Fisher Asset Management LLC now owns 3,236 shares of the company’s stock worth $258,000 after purchasing an additional 2,947 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Colgate-Palmolive from $104.00 to $107.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Bank of America raised their price objective on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Argus raised their price objective on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a research report on Wednesday, May 15th. Finally, BNP Paribas started coverage on shares of Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 price objective on the stock. Eight equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $101.11.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the sale, the executive vice president now owns 10,377 shares in the company, valued at approximately $1,069,868.70. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,490 shares of company stock worth $4,486,063. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL traded up $0.69 during trading on Friday, reaching $106.50. The stock had a trading volume of 5,033,762 shares, compared to its average volume of 4,329,917. The stock has a fifty day simple moving average of $100.11 and a two-hundred day simple moving average of $93.61. The firm has a market capitalization of $87.38 billion, a price-to-earnings ratio of 33.70, a P/E/G ratio of 3.54 and a beta of 0.39. The company has a quick ratio of 0.28, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $106.72.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter last year, the company posted $0.77 earnings per share. As a group, analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a $0.50 dividend. The ex-dividend date was Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 1.88%. Colgate-Palmolive’s payout ratio is 63.29%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.